2016
DOI: 10.2967/jnumed.115.171553
|View full text |Cite
|
Sign up to set email alerts
|

Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation

Abstract: Macrophages are cellular mediators of vascular inflammation and are involved in the formation of atherosclerotic plaques. These immune cells secrete proteases such as matrix metalloproteinases and cathepsins that contribute to disease formation and progression. Here, we demonstrate that activity-based probes (ABPs) targeting cysteine cathepsins can be used in murine models of atherosclerosis to noninvasively image activated macrophage populations using both optical and PET/CT methods. The probes can also be us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 47 publications
(30 citation statements)
references
References 41 publications
1
24
1
Order By: Relevance
“…took a major step towards translating molecular imaging into clinical practice by developing a dual‐modality ABP for positron emission tomography–computed tomography and optical analysis. That study showed that the novel molecular agent can accurately discriminate between inflamed and normal arteries in vivo , and ex vivo sections from these animals further supported their findings by showing that the fluorescence signal colocalized with activated macrophages . The authors also demonstrated encouraging data using this imaging modality for idiopathic pulmonary fibrosis in human subjects , which further support their utility in the clinical arena.…”
Section: Harnessing Cysteine Cathepsins For Diagnosis and Therapeuticsupporting
confidence: 52%
“…took a major step towards translating molecular imaging into clinical practice by developing a dual‐modality ABP for positron emission tomography–computed tomography and optical analysis. That study showed that the novel molecular agent can accurately discriminate between inflamed and normal arteries in vivo , and ex vivo sections from these animals further supported their findings by showing that the fluorescence signal colocalized with activated macrophages . The authors also demonstrated encouraging data using this imaging modality for idiopathic pulmonary fibrosis in human subjects , which further support their utility in the clinical arena.…”
Section: Harnessing Cysteine Cathepsins For Diagnosis and Therapeuticsupporting
confidence: 52%
“…Hence, it is possible to find other examples of activatable optical probes for plaque imaging based on the selective detection of Cathepsin B. This is the case for the work published by Withana et al who developed a molecular activatable probe sensitive to Cathepsin B whose structure is schematically drawn in Figure a . This molecular fluorescent structure showed a great intensity enhancement in presence of Cathepsin B and the authors used it for in vivo plaque imaging in an experimental atherosclerotic murine model.…”
Section: Optical Nanoparticles For Atherosclerosis Imagingmentioning
confidence: 99%
“…c) Corresponding in situ fluorescence imaging of the activatable fluorescent probe in murine carotid arteries and control healthy mouse. Reproduced with permission . Copyright 2016, Society of Nuclear Medicine and Molecular Imaging.…”
Section: Optical Nanoparticles For Atherosclerosis Imagingmentioning
confidence: 99%
“… 102 The PET/SPECT probes for cathepsins have been recently reviewed, 103 and only a few articles on nuclear imaging of cathepsins have appeared since. 104 - 106 …”
Section: Ec 34: Proteasesmentioning
confidence: 99%